Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13958535
[patent_doc_number] => 20190055611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => PRIMER PAIR, KIT AND METHOD FOR DETECTING BABESIA GIBSONI
[patent_app_type] => utility
[patent_app_number] => 15/683987
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15683987
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/683987 | Primer pair, kit and method for detecting | Aug 22, 2017 | Issued |
Array
(
[id] => 14504409
[patent_doc_number] => 20190195859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => DETERMINING THE RISK OF SCOLIOSIS COMPRISING DETERMINING CELLULAR RESPONSE TO MECHANOSTIMULATION
[patent_app_type] => utility
[patent_app_number] => 16/327278
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327278 | DETERMINING THE RISK OF SCOLIOSIS COMPRISING DETERMINING CELLULAR RESPONSE TO MECHANOSTIMULATION | Aug 22, 2017 | Abandoned |
Array
(
[id] => 13690185
[patent_doc_number] => 20170356047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => METHOD TO PREDICT THE PATTERN OF LOCOMOTION IN HORSES
[patent_app_type] => utility
[patent_app_number] => 15/682124
[patent_app_country] => US
[patent_app_date] => 2017-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15682124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/682124 | Method to predict the pattern of locomotion in horses | Aug 20, 2017 | Issued |
Array
(
[id] => 15282165
[patent_doc_number] => 10513740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-24
[patent_title] => Primer pair, kit and method for detecting anaplasma platys
[patent_app_type] => utility
[patent_app_number] => 15/678732
[patent_app_country] => US
[patent_app_date] => 2017-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2132
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15678732
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/678732 | Primer pair, kit and method for detecting anaplasma platys | Aug 15, 2017 | Issued |
Array
(
[id] => 14582023
[patent_doc_number] => 20190218620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 16/324366
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324366
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324366 | Detection of CLDN18-ARHGAP6 fusion gene or CLDN18-ARHGAP26 fusion gene in pancreatic cancer | Aug 8, 2017 | Issued |
Array
(
[id] => 12219508
[patent_doc_number] => 20180057866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'GENETIC PROFILING METHODS FOR PREDICTION OF TASTE AND SCENT PREFERENCES AND GUSTATIVE AND OLFACTIVE PRODUCT SELECTION'
[patent_app_type] => utility
[patent_app_number] => 15/671160
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19461
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/671160 | GENETIC PROFILING METHODS FOR PREDICTION OF TASTE AND SCENT PREFERENCES AND GUSTATIVE AND OLFACTIVE PRODUCT SELECTION | Aug 7, 2017 | Abandoned |
Array
(
[id] => 12179023
[patent_doc_number] => 20180037959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'Process using ZEN hydrolysis probe for detection of porcine contamination and a kit thereof'
[patent_app_type] => utility
[patent_app_number] => 15/672194
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5697
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672194 | Process using ZEN hydrolysis probe for detection of porcine contamination and a kit thereof | Aug 7, 2017 | Abandoned |
Array
(
[id] => 12607422
[patent_doc_number] => 20180094304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => USE OF GENETIC PROFILING FOR PREDICTION OF WINE TASTE PREFERENCES AND WINE SELECTION
[patent_app_type] => utility
[patent_app_number] => 15/671161
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671161
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/671161 | USE OF GENETIC PROFILING FOR PREDICTION OF WINE TASTE PREFERENCES AND WINE SELECTION | Aug 7, 2017 | Abandoned |
Array
(
[id] => 14343143
[patent_doc_number] => 20190153544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHODS FOR GYNECOLOGIC NEOPLASM DIAGNOSIS
[patent_app_type] => utility
[patent_app_number] => 16/321238
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321238
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321238 | METHODS FOR GYNECOLOGIC NEOPLASM DIAGNOSIS | Jul 27, 2017 | Abandoned |
Array
(
[id] => 12059064
[patent_doc_number] => 20170335407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'METHOD FOR DETECTING METHYLATION OF COLORECTAL CANCER SPECIFIC METHYLATION MARKER GENE FOR COLORECTAL CANCER DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/661054
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23178
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661054
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/661054 | Method for detecting methylation of colorectal cancer specific methylation marker gene for colorectal cancer diagnosis | Jul 26, 2017 | Issued |
Array
(
[id] => 14375773
[patent_doc_number] => 20190161799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => Marker and Method for Determining the Composition or Purity of a Cell Culture and for Determining In Vitro the Identity of a Cartilage Cell or Synovial Cell
[patent_app_type] => utility
[patent_app_number] => 16/321151
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321151
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321151 | Marker and Method for Determining the Composition or Purity of a Cell Culture and for Determining In Vitro the Identity of a Cartilage Cell or Synovial Cell | Jul 24, 2017 | Abandoned |
Array
(
[id] => 14868773
[patent_doc_number] => 20190284628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => Extracellular mRNA Markers of Muscular Dystrophies in Human Urine
[patent_app_type] => utility
[patent_app_number] => 16/318658
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318658
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318658 | Extracellular mRNA markers of muscular dystrophies in human urine | Jul 20, 2017 | Issued |
Array
(
[id] => 15483673
[patent_doc_number] => 10557170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Thromboembolic disease markers
[patent_app_type] => utility
[patent_app_number] => 15/651017
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 11963
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651017
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651017 | Thromboembolic disease markers | Jul 16, 2017 | Issued |
Array
(
[id] => 14653531
[patent_doc_number] => 20190233894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => METHODS OF DIAGNOSIS ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/318651
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318651 | METHODS OF DIAGNOSIS ALZHEIMER'S DISEASE | Jul 13, 2017 | Abandoned |
Array
(
[id] => 14685711
[patent_doc_number] => 20190241970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => METHOD FOR DETERMINING LIKELIHOOD OF COLORECTAL CANCER DEVELOPMENT
[patent_app_type] => utility
[patent_app_number] => 16/315961
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315961 | METHOD FOR DETERMINING LIKELIHOOD OF COLORECTAL CANCER DEVELOPMENT | Jul 6, 2017 | Abandoned |
Array
(
[id] => 14930653
[patent_doc_number] => 20190300964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => COLON CANCER METHYLATION MARKERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315608
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315608 | COLON CANCER METHYLATION MARKERS AND USES THEREOF | Jul 5, 2017 | Pending |
Array
(
[id] => 14930655
[patent_doc_number] => 20190300965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => LIVER CANCER METHYLATION MARKERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315609
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315609
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315609 | LIVER CANCER METHYLATION MARKERS AND USES THEREOF | Jul 5, 2017 | Pending |
Array
(
[id] => 15178921
[patent_doc_number] => 20190360052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => BREAST AND OVARIAN CANCER METHYLATION MARKERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315605
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315605 | Breast and ovarian cancer methylation markers and uses thereof | Jul 5, 2017 | Issued |
Array
(
[id] => 15117855
[patent_doc_number] => 20190345560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => LUNG CANCER METHYLATION MARKERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315610
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315610
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315610 | LUNG CANCER METHYLATION MARKERS AND USES THEREOF | Jul 5, 2017 | Pending |
Array
(
[id] => 11994294
[patent_doc_number] => 20170298449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'GENE EXPRESSION SIGNATURES FOR DETECTION OF UNDERLYING PHILADELPHIA CHROMOSOME-LIKE (PH-LIKE) EVENTS AND THERAPEUTIC TARGETING IN LEUKEMIA'
[patent_app_type] => utility
[patent_app_number] => 15/638926
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23198
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15638926
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/638926 | GENE EXPRESSION SIGNATURES FOR DETECTION OF UNDERLYING PHILADELPHIA CHROMOSOME-LIKE (PH-LIKE) EVENTS AND THERAPEUTIC TARGETING IN LEUKEMIA | Jun 29, 2017 | Abandoned |